The ResearchWorks Podcast

The ResearchWorks Podcast

By Dr Dayna Pool and Dr Ashleigh ThorntonScienceMedicineHealth & FitnessEducation
Download on the App Store

The ResearchWorks Podcast episodes

  • Episode 30 (Dr Michelle Jackman)
    Interventions to improve physical function for children and young people with cerebral palsy: international clinical practice guideline

    Michelle Jackman, Leanne Sakzewski, Catherine Morgan, Roslyn N Boyd, Sue E Brennan, Katherine Langdon, Rachel A M Toovey, Susan Greaves, Megan Thorley, Iona Novak,

    First published: 21 September 2021

     https://doi.org/10.1111/dmcn.15055

    Abstract

    Aim

    To provide recommendations for interventions to improve physical function for children and young people with cerebral palsy.


    Method

    An expert panel prioritized questions and patient-important outcomes. Using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methods, the panel assessed the certainty of evidence and made recommendations, with international expert and consumer consultation.


    Results

    The guideline comprises 13 recommendations (informed by three systematic reviews, 30 randomized trials, and five before–after studies). To achieve functional goals, it is recommended that intervention includes client-chosen goals, whole-task practice within real-life settings, support to empower families, and a team approach. Age, ability, and child/family preferences need to be considered. To improve walking ability, overground walking is recommended and can be supplemented with treadmill training. Various approaches can facilitate hand use goals: bimanual therapy, constraint-induced movement therapy, goal-directed training, and cognitive approaches. For self-care, whole-task practice combined with assistive devices can increase independence and reduce caregiver burden. Participation in leisure goals can combine whole-task practice with strategies to address environmental, personal, and social barriers.


    Interpretation

    Intervention to improve function for children and young people with cerebral palsy needs to include client-chosen goals and whole-task practice of goals. Clinicians should consider child/family preferences, age, and ability when selecting specific interventions.

    56 min
  • Episode 29 (Associate Professor Jenny Downs)
    Environmental enrichment intervention for Rett syndrome: an individually randomised stepped wedge trial

    Jenny Downs, Jenny Rodger, Chen Li , Xuesong Tan, Nan Hu, Kingsley Wong , Nicholas de Klerk , Helen Leonard

    Affiliations expand

    • PMID: 29321033
    • PMCID: PMC5764021
    • DOI: 10.1186/s13023-017-0752-8
    • Free PMC article

    Abstract

    Background: Rett syndrome is caused by a pathogenic mutation in the MECP2 gene with major consequences for motor and cognitive development. One of the effects of impaired MECP2 function is reduced production of Brain Derived Neurotrophic Factor (BDNF), a protein required for normal neuronal development. When housed in an enriched environment, MECP2 null mice improved motor abilities and increased levels of BDNF in the brain. We investigated the effects of environmental enrichment on gross motor skills and blood BDNF levels in girls with Rett syndrome.

    Methods: A genetically variable group of 12 girls with a MECP2 mutation and younger than 6 years participated in a modified individually randomised stepped wedge design study. Assessments were conducted on five occasions, two during the baseline period and three during the intervention period. Gross motor function was assessed using the Rett Syndrome Gross Motor Scale (maximum score of 45) on five occasions, two during the baseline period and three during the intervention period. Blood levels of BDNF were measured at the two baseline assessments and at the end of the intervention period. The intervention comprised motor learning and exercise supplemented with social, cognitive and other sensory experiences over a six-month period.

    Results: At the first assessment, the mean (SD) age of the children was 3 years (1 year 1 month) years ranging from 1 year 6 months to 5 years 2 months. Also at baseline, mean (SD) gross motor scores and blood BDNF levels were 22.7/45 (9.6) and 165.0 (28.8) ng/ml respectively. Adjusting for covariates, the enriched environment was associated with improved gross motor skills (coefficient 8.2, 95%CI 5.1, 11.2) and a 321.4 ng/ml (95%CI 272.0, 370.8) increase in blood BDNF levels after 6 months of treatment. Growth, sleep quality and mood were unaffected.

    Conclusions: Behavioural interventions such as environmental enrichment can reduce the functional deficit in Rett syndrome, contributing to the evidence-base for management and further understanding of epigenetic mechanisms. Environmental enrichment will be an important adjunct in the evaluation of new drug therapies that use BDNF pathways because of implications for the strengthening of synapses and improved functioning.

    Trial registration: ACTRN12615001286538 .

    Keywords: BDNF; Environmental enrichment; Neurodevelopmental disorder; Neuroplasticity; Rett syndrome.

    47 min
  • Episode 28 (Mid-Season Announcement!)

    Thank you for listening to the ResearchWorks podcast! It's our pleasure to bring you the behind the scenes stories and interviews with some of the best researchers from Australia and across the globe!

    Dr Ash and Dr Dayna are currently on a mid-season break but stay tuned for a special announcement about our future plans, the CPD reporting for 2021 and some amazing stats about the Pod!

    We do it all for our amazing community, in our spare time and it's all about bringing Evidence Based Practice (EBP) to the fore. The whole point of EBP is to combine empirical/scientific information with clinical expertise, combined again with the values of the patient/client/child and family. 

    The "consumer" should always be at the heart of everything that we do and we should always remember our priorities - it helps us to stay really motivated to find better solutions to improve patient care.

    Season 2 will begin in a couple of weeks time and we hope you can join us once again!

    5 min
  • Episode 27 (Dr Roslyn Ward)
    Clinical utilisation of the Infant Monitor of vocal Production (IMP) for early identification of communication impairment in young infants at-risk of cerebral palsy: a prospective cohort study


    R Ward, N Hennessey, E Barty, C Elliott, J Valentine & R Cantle Moore

    ABSTRACT

    Aim: To report prospective longitudinal data of early vocalisations of infants identified “at-risk” of cerebral palsy (CP) for early identification of communication impairment.

    Method: This case-control longitudinal prospective cohort study reports on the assessment of 36 infants, 18 identified as at-risk of CP at the time of enrolment and 18 typically developing (TD) children, at three time points: 6 months, 9 months and 12 months of age, Data were obtained through criterion and norm referenced assessments of vocalisation behaviours.

    Results: Early vocal behaviours of infants identified as at-risk of CP did not differ from their age matched peers at 6 months of age, however, significant group differences emerged at 9 and 12 months when pre-canonical and canonical babble typically emerge. Generalised linear mixed models analysis showed that the rate of development of early language ability and more complex speech-related vocal behaviours was slower for infants at risk of CP when compared to TD infants, with over 75% of infants with CP showing below normal vocal production and impaired language by 12 months of age.

    Interpretation: Our data suggest characteristics of infant vocalisations associated with pre-canonical and canonical babbling provide a strong evidence base for predicting communication outcomes in infants at risk of CP.

    https://doi.org/10.1080/17518423.2021.1942280

    46 min
  • Episode 26 (Professor Egmar Longo and Professor Ana Carolina de Campos)
    Let's make pediatric physical therapy a true evidence-based field! Can we count on you?


    Egmar Longo,  Ana Carolina de Campos, and Robert J. Palisano


    It has been five years since the publication of the systematic review by Novak et al.1 that reported levels of evidence for 64 interventions for children with cerebral palsy (CP) across the world – green light (do it), yellow light (moderate evidence – assess the results) and lack of evidence (don’t do it). We are challenged to think about what has changed in the national and international scenario: are we the same physical therapists as 5, 10, or 20 years ago? Have we changed our practice to keep up with best evidence and family-centered services that engage children and families in goal-setting and intervention planning?

    Our reflection today is: which side do you support? Are you a knowledge-broker or an active resistor? We need more activists to change the current scenario. Together we can promote evidence-based practice in pediatric physical therapy and give all children and families the best care that they deserve. Can we count on you?

    52 min
  • Episode 25 (Dr Melissa Licari)

    IMPACT FOR DCD (Developmental Coordination Disorder)

    Names of Investigators:
    Dr Melissa Licari, Dr Jacqueline Williams, Dr Gail Alvares, Charmain Bernie, Wesley Billingham, Dr Paola Chivers, Dr Matthew Cooper, Georgina Earl, A/Prof Jenny Downs, Brian Elbers, Samantha Elbers, Prof Catherine Elliott, Dr Kiah Evans, Dr Tamika Heiden, Dr Leanne Lester, A/Prof Fleur McIntyre, Dr Sarah McIntyre, Prof Jan Piek, Sarah Pillar, Dr Siobhan Reid, Dr Jess Reynolds, Prof Alicia Spittle, Dr Renee Teal, Dr Ashleigh Thornton, Prof Andrew Whitehouse

    What is Impact for DCD?
    Impact for DCD is the largest survey conducted to identify the challenges experienced by children with Developmental Coordination Disorder (DCD) and their families. This national survey (based on N=443 children 4-18 years) examined challenges relating to obtaining a diagnosis, impact of the disorder on activity and participation, difficulties encountered in the school environment, access to therapy, and the social and emotional impacts on the child and their family.

    What did the Impact for DCD report tell us?
    There is no consistent terminology or standardised practice for the diagnosis of DCD in Australia. Many children are not receiving a diagnosis until two to four years after seeking help.

    More than half of families (58%) do not have access to funding to support the cost of therapy and many reported (53%) that accessing therapy caused financial strain.

    Parents reported that teacher knowledge and awareness of DCD is the greatest challenge at school. Many parents felt their child’s learning needs were not being met. One in four parents reported that their child did not enjoy going to school and 62% of children had difficulty making friends.

    Almost all parents (92%) were concerned about the impact their child’s movement difficulties were having on their social and emotional health. Two thirds of children scored in the clinically concerning ranges for emotional symptoms and peer problems. Many parents (74%) reported experiencing frequent emotional worry about their child’s movement difficulties and 78% of parents were concerned about their child’s future.

    Based on the findings of the Impact for DCD survey and the priority areas identified by families completing the survey, we have provided a list of key recommendations which were developed in collaboration with family and professional reference groups. 

    50 min
  • Episode 24 (Dr Vivienne Travlos)
    Mental wellbeing in non-ambulant youth with neuromuscular disorders: What makes the difference?


    Vivienne Travlos , Jenny Downs , Andrew Wilson , Dana Hince , Shane Patman

    • PMID: 30606465
    • DOI: 10.1016/j.nmd.2018.08.013

    Abstract

    The physical and social challenges associated with neuromuscular disorders may impact mental wellbeing in non-ambulant youth during the more vulnerable period of adolescence. This cross-sectional survey investigated non-ambulant youths' mental wellbeing and relationships with physical health, participation and social factors. 

    The conceptual model was the International Classification of Functioning, Disability and Health (ICF). Thirty-seven youth aged 13-22 years old (mean age 17.4 years; n = 30 male; n = 24 Duchenne Muscular Dystrophy) and their parents provided biopsychosocial data through a comprehensive self-report questionnaire. 

    The primary outcome measure was the Warwick Edinburgh Mental Wellbeing Scale (WEMWBS). Relationships between mental wellbeing and variables within and across each ICF domain were explored using linear regression models. Mean WEMWBS scores (55.3/70 [SD 8.1]) were higher than for typically developing youth and comparable to youth with other chronic conditions. Over half of youth reported severe co-morbidities across all body systems. 

    Multivariable modelling indicated that mental wellbeing was independently associated with academic achievement and perceived family support but not with physical health variables. Beyond management of physical co-morbidities, enabling youths' educational attainment and attending to social support likely optimises youth's wellbeing.

    41 min
  • Episode 23 (Part 2 - Clinical Professor Gareth Baynam)

    DIGIT-ALL: RARE DISEASES

    Rare Diseases - a 2 part special!

    Rare diseases are increasingly recognised as a global public health priority and contribute to significant and disproportionately high health system impacts. Accordingly, they present clinical and public health challenges, as well as opportunities for digital health solutions across the lifespan, including improved diagnosis, treatment, navigation and care coordination, and integration and coordination for broader societal and patient wellbeing. People living with rare diseases, individually and cumulatively, are digital disruptors. 

    In this manuscript the authors describe some of the unique dynamics of the rare disease domain as they currently, or have the potential to in the future, apply to digital health; highlight some recent international rare diseases digital health initiatives; and touch upon implications for those with more common disorders.

    Dr Gareth Baynam is a Clinical Geneticist working in Western Australia with a long-standing commitment to improved Indigenous health care.  Dr Baynam works to develop and deliver genetic health care in partnership with Aboriginal health leaders and the community.  

    Among current activities, Dr Baynam is a practising Clinical Geneticist, a Clinical Genomics Policy Advisor at WA Health, Director of the Undiagnosed Diseases Program, a co-director of genetic and rare diseases research at the Telethon Kids Institute, and a member of the International Scientific Advisory Board of the new pan-European Union genomic and multi-omic initiative for rare diseases (Solve-RD).

    35 min
  • Episode 22 (Part 1 - Clinical Professor Gareth Baynam)

    DIGIT-ALL: RARE DISEASES

    Rare Diseases - a 2 part special!

    Rare diseases are increasingly recognised as a global public health priority and contribute to significant and disproportionately high health system impacts. Accordingly, they present clinical and public health challenges, as well as opportunities for digital health solutions across the lifespan, including improved diagnosis, treatment, navigation and care coordination, and integration and coordination for broader societal and patient wellbeing. People living with rare diseases, individually and cumulatively, are digital disruptors. 

    In this manuscript the authors describe some of the unique dynamics of the rare disease domain as they currently, or have the potential to in the future, apply to digital health; highlight some recent international rare diseases digital health initiatives; and touch upon implications for those with more common disorders.

    Dr Gareth Baynam is a Clinical Geneticist working in Western Australia with a long-standing commitment to improved Indigenous health care.  Dr Baynam works to develop and deliver genetic health care in partnership with Aboriginal health leaders and the community.  

    Among current activities, Dr Baynam is a practising Clinical Geneticist, a Clinical Genomics Policy Advisor at WA Health, Director of the Undiagnosed Diseases Program, a co-director of genetic and rare diseases research at the Telethon Kids Institute, and a member of the International Scientific Advisory Board of the new pan-European Union genomic and multi-omic initiative for rare diseases (Solve-RD).

    32 min
  • Episode 21 (Dr Ulrica Jonsson)
    Changes in walking ability, intellectual disability, and epilepsy in adults with cerebral palsy over 50 years: a population-based follow-up study


    Ulrica Jonsson, Meta Nyström Eek, Katharina Stibrant Sunnerhagen, Kate Himmelmann

    • PMID: 33772773
    • DOI: 10.1111/dmcn.14871

    Abstract

    Aim:
    To determine if walking ability and presence of intellectual disability and epilepsy change from childhood to 50 years of age in individuals with cerebral palsy (CP), and if such changes are related to age, sex, or CP subtype.

    Method: This was a population-based follow-up study of 142 adults born from 1959 to 1978 (82 males, 60 females; mean age 48y 4mo, range 37-58y; 44% unilateral, 35% bilateral, 17% dyskinetic, and 4% ataxic CP) listed in the CP register of western Sweden. We compared childhood data with a follow-up assessment in 2016.

    Results: At follow-up, walking ability had changed significantly (p<0.001). The proportion of participants walking without aids had decreased from 71% to 62%, and wheelchair ambulation increased from 18% to 25%. Walking ability was related to subtype (p=0.001), but not to age, sex, pain, fatigue, or body mass index. The proportion classified as having intellectual disability had increased from 16% to 22% (p=0.039) and the proportion with epilepsy from 9% to 18% (p=0.015). Of those with childhood epilepsy, 46% were seizure-free without medication.

    Interpretation: Walking ability and the presence of intellectual disability and epilepsy had changed significantly since childhood. Life-long access to specialized health care is warranted for re-evaluation of impairments, treatment, and assistance. What this paper adds Changes in impairments in individuals with cerebral palsy (CP) over time are related to CP subtype. After 50 years, walking ability in CP may have deteriorated or improved. Intellectual disability in CP may not always be detected in early childhood assessments. Epilepsy in CP may develop after childhood or may be outgrown.

    39 min

About The ResearchWorks Podcast

From the publisher's feed

The Research Works podcast is designed for health professionals in the area of child health, where we discuss emerging, modern, evidence based research - the behind the scenes stories, interviews…